Methylenetetrahydrofolate reductase (MTHFR) gene C677T polymorphism and risk of preeclampsia: An updated meta-analysis based on 51 studies

Archives of Medical Research

Volumn 44, Issue 3, 2013, Pages 159-168

  Wang, Xi Mei ^a   Wu, Hai Yan ^a   Qiu, Xu Jun ^a  

^a JIANGNAN UNIVERSITY   (China)

Author keywords

Homocysteine; Meta analysis; MTHFR; Polymorphism; Preeclampsia

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2);

ARTICLE; ASIA; CAUCASIAN; ENZYME POLYMORPHISM; GENETIC ASSOCIATION; GENETIC MODEL; HUMAN; META ANALYSIS; PREECLAMPSIA; RISK FACTOR;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CONFIDENCE INTERVALS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FAR EAST; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); ODDS RATIO; POLYMORPHISM, GENETIC; PRE-ECLAMPSIA; PREGNANCY; SAMPLE SIZE;

EID: 84876851366     PISSN: 01884409     EISSN: 18735487     Source Type: Journal    
DOI: 10.1016/j.arcmed.2013.01.011     Document Type: Article

References (85)

1. Zhang J., Zeisler J., Hatch M.C., et al. Epidemiology of pregnancy-induced hypertension. Epidemiol Rev 1997, 19:218-232.
2. Kim Y.J., Williamson R.A., Chen K., et al. Lipoprotein lipase gene mutations and the genetic susceptibility of preeclampsia. Hypertension 2001, 38:992-996.
3. Laivuori H. Genetic aspects of preeclampsia. Front Biosci 2007, 12:2372-2382.
4. Patrick T.E., Powers R.W., Daftary A.R., et al. Homocysteine and folic acid are inversely related in black women with preeclampsia. Hypertension 2004, 43:1279-1282.
5. Laivuori H., Kaaja R., Turpeinen U., et al. Plasma homocysteine levels elevated and inversely related to insulin sensitivity in preeclampsia. Obstet Gynecol 1999, 93:489-493.
6. Goddijn-Wessel T.A., Wouters M.G., de Molen E.F., et al. Hyperhomocysteinemia: a risk factor for placental abruption or infarction. Eur J Obstet Gynecol Reprod Biol 1996, 66:23-29.
7. Wouters M.G., Boers G.H., Blom H.J., et al. Hyperhomocysteinemia: a risk factor in women with unexplained recurrent early pregnancy loss. Fertil Steril 1993, 60:820-825.
8. Steegers-Theunissen R.P., Boers G.H., Trijbels F.J., et al. Maternal hyperhomocysteinemia: a risk factor for neural-tube defects. Metabolism 1994, 43:1475-1480.
9. Stuhlinger M.C., Tsao P.S., Her J.H., et al. Homocysteine impairs the nitric oxide synthase pathway: role of asymmetric dimethylarginine. Circulation 2001, 104:2569-2575.
10. Xuan C., Chang F.J., Liu X.C., et al. Endothelial nitric oxide synthase enhancer for protection of endothelial function from asymmetric dimethylarginine-induced injury in human internal thoracic artery. J Thorac Cardiovasc Surg 2012, 144:697-703.
11. Goyette P., Sumner J.S., Milos R., et al. Human methylenetetrahydrofolate reductase: isolation of cDNA, mapping and mutation identification. Nat Genet 1994, 7:195-200.
12. Frosst P., Blom H.J., Milos R., et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995, 10:111-113.
13. Brattstrom L., Wilcken D.E., Ohrvik J., et al. Common methylenetetrahydrofolate reductase gene mutation leads to hyperhomocysteinemia but not to vascular disease: the result of a meta-analysis. Circulation 1998, 98:2520-2526.
14. Kupferminc M.J., Eldor A., Steinman N., et al. Increased frequency of genetic thrombophilia in women with complications of pregnancy. N Engl J Med 1999, 340:9-13.
15. Makris M. Hyperhomocysteinemia and thrombosis. Clin Lab Haematol 2000, 22:133-143.
16. Kluijtmans L.A., Kastelein J.J., Lindemans J., et al. Thermolabile methylenetetrahydrofolate reductase in coronary artery disease. Circulation 1997, 96:2573-2577.
17. Kosmas I.P., Tatsioni A., Ioannidis J.P. Association of C677T polymorphism in the methylenetetrahydrofolate reductase gene with hypertension in pregnancy and pre-eclampsia: a meta-analysis. J Hypertens 2004, 22:1655-1662.
18. Xia X.P., Chang W.W., Cao Y.X. Meta-analysis of the methylenetetrahydrofolate reductase C677T polymorphism and susceptibility to pre-eclampsia. Hypertens Res 2012, 35:1129-1134.
19. Xuan C., Zhang B.B., Yang T., et al. Association between OCTN1/2 gene polymorphisms (1672C-T, 207G-C) and susceptibility of Crohn's disease: a meta-analysis. Int J Colorectal Dis 2012, 27:11-19.
20. Xuan C., Zhang B.B., Li M., et al. No association between APOE epsilon 4 allele and multiple sclerosis susceptibility: a meta-analysis from 5472 cases and 4727 controls. J Neurol Sci 2011, 308:110-116.
21. Xuan C., Bai X.Y., Gao G., et al. Association between polymorphism of methylenetetrahydrofolate reductase (MTHFR) C677T and risk of myocardial infarction: a meta-analysis for 8,140 cases and 10,522 controls. Arch Med Res 2011, 42:677-685.
22. Lin J., August P. Genetic thrombophilias and preeclampsia: a meta-analysis. Obstet Gynecol 2005, 105:182-192.
23. Kaiser T., Brennecke S.P., Moses E.K. C677T methylenetetrahydrofolate reductase polymorphism is not a risk factor for pre-eclampsia/eclampsia among Australian women. Hum Hered 2001, 51:20-22.
24. Zusterzeel P.L., Visser W., Blom H.J., et al. Methylenetetrahydrofolate reductase polymorphisms in preeclampsia and the HELLP syndrome. Hypertens Pregnancy 2000, 19:299-307.
25. Stonek F., Hafner E., Metzenbauer M., et al. Carriage of the methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism does not influence the first and second trimester uterine artery Doppler flow. Eur J Obstet Gynecol Reprod Biol 2008, 140:178-182.
26. Kupferminc M.J., Fait G., Many A., et al. Severe preeclampsia and high frequency of genetic thrombophilic mutations. Obstet Gynecol 2000, 96:45-49.
27. Lauszus F.F., Grøn P.L., Klebe J.G. Association of polymorphism of methylenetetrahydrofolate reductase with urinary albumin excretion rate in type 1 diabetes mellitus but not with preeclampsia, retinopathy, and preterm delivery. Acta Obstet Gynecol Scand 2001, 80:803-806.
28. Powers R.W., Dunbar M.S., Gallaher M.J., et al. The 677 C-T methylenetetrahydrofolate reductase mutation does not predict increased maternal homocysteine during pregnancy. Obstet Gynecol 2003, 101:762-766.
29. Jarvenpaa J., Pakkila M., Savolainen E.R., et al. Evaluation of factor V Leiden, prothrombin and methylenetetrahydrofolate reductase gene mutations in patients with severe pregnancy complications in northern Finland. Gynecol Obstet Invest 2006, 62:28-32.
30. Yalinkaya A., Erdemoglu M., Akdeniz N., et al. The relationship between thrombophilic mutations and preeclampsia: a prospective case-control study. Ann Saudi Med 2006, 26:105-109.
31. Sohda S., Arinami T., Hamada H., et al. Methylenetetrahydrofolate reductase polymorphism and pre-eclampsia. J Med Genet 1997, 34:525-526.
32. Grandone E., Margaglione M., Colaizzo D., et al. Factor V Leiden, C>T MTHFR polymorphism and genetic susceptibility to preeclampsia. Thromb Haemost 1997, 77:1052-1054.
33. Chikosi A.B., Moodley J., Pegoraro R.J., et al. 5,10 methylenetetrahydrofolate reductase polymorphism in black South African women with pre-eclampsia. Br J Obstet Gynaecol 1999, 106:1219-1220.
34. O'Shaughnessy K.M., Fu B., Ferraro F., et al. Factor V Leiden and thermolabile methylenetetrahydrofolate reductase gene variants in an East Anglian preeclampsia cohort. Hypertension 1999, 33:1338-1341.
35. Powers R.W., Minich L.A., Lykins D.L., et al. Methylenetetrahydrofolate reductase polymorphism, folate, and susceptibility to preeclampsia. J Soc Gynecol Investig 1999, 6:74-79.
36. Laivuori H., Kaaja R., Ylikorkala O., et al. 677 C-->T polymorphism of the methylenetetrahydrofolate reductase gene and preeclampsia. Obstet Gynecol 2000, 96:277-280.
37. Kobashi G., Yamada H., Asano T., et al. Absence of association between a common mutation in the methylenetetrahydrofolate reductase gene and preeclampsia in Japanese women. Am J Med Genet 2000, 93:122-125.
38. Rigo J., Nagy B., Fintor L., et al. Maternal and neonatal outcome of preeclamptic pregnancies: the potential roles of factor V Leiden mutation and 5,10 methylenetetrahydrofolate reductase. Hypertens Pregnancy 2000, 19:163-172.
39. 12 concentrations, and risk of preeclampsia among black African women from Zimbabwe. Mol Genet Metab 2000, 69:33-39.
40. Kaiser T., Brennecke S.P., Moses E.K. Methylenetetrahydrofolate reductase polymorphisms are not a risk factor for pre-eclampsia/eclampsia in Australian women. Gynecol Obstet Invest 2000, 50:100-102.
41. Li K., Zheng D., Xue Y., et al. The common C677T polymorphism in the methylenetetrahydrofolate reductase gene is associated with neural tube defects and preeclampsia. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 2000, 17:76-78. (in Chinese).
42. Kupferminc M.J., Fait G., Many A., et al. Low-molecular-weight heparin for the prevention of obstetric complications in women with thrombophilias. Hypertens Pregnancy 2001, 20:35-44.
43. Kim Y.J., Williamson R.A., Murray J.C., et al. Genetic susceptibility to preeclampsia: roles of cytosine-to-thymine substitution at nucleotide 677 of the gene for methylenetetrahydrofolate reductase, 68-base pair insertion at nucleotide 844 of the gene for cystathionine beta-synthase, and factor V Leiden mutation. Am J Obstet Gynecol 2001, 184:1211-1217.
44. Raijmakers M.T., Zusterzeel P.L., Steegers E.A., et al. Hyperhomocysteinaemia: a risk factor for preeclampsia. Eur J Obstet Gynecol Reprod Biol 2001, 95:226-228.
45. Livingston J.C., Barton J.R., Park V., et al. Maternal and fetal inherited thrombophilias are not related to the development of severe preeclampsia. Am J Obstet Gynecol 2001, 185:153-157.
46. Lachmeijer A.M., Arngrimsson R., Bastiaans E.J., et al. Mutations in the gene for methylenetetrahydrofolate reductase, homocysteine levels, and vitamin status in women with a history of preeclampsia. Am J Obstet Gynecol 2001, 184:394-402.
47. Watanabe H., Hamada H., Yamakawa-Kobayashi K., et al. Evidence for an association of the R485K polymorphism in the coagulation factor V gene with severe preeclampsia from screening 35 polymorphisms in 27 candidate genes. Thromb Haemost 2001, 86:1594-1595.
48. Alfirevic Z., Mousa H.A., Martlew V., et al. Postnatal screening for thrombophilia in women with severe pregnancy complications. Obstet Gynecol 2001, 97:753-759.
49. Prasmusinto D., Skrablin S., Hofstaetter C., et al. The methylenetetrahydrofolate reductase 677 C-->T polymorphism and preeclampsia in two populations. Obstet Gynecol 2002, 99:1085-1092.
50. Morrison E.R., Miedzybrodzka Z.H., Campbell D.M., et al. Prothrombotic genotypes are not associated with pre-eclampsia and gestational hypertension: results from a large population-based study and systematic review. Thromb Haemost 2002, 87:779-785.
51. D'Elia A.V., Driul L., Giacomello R., et al. Frequency of factor V, prothrombin and methylenetetrahydrofolate reductase gene variants in preeclampsia. Gynecol Obstet Invest 2002, 53:84-87.
52. Fabbro D., D'Elia A.V., Spizzo R., et al. Association between plasminogen activator inhibitor 1 gene polymorphisms and preeclampsia. Gynecol Obstet Invest 2003, 56:17-22.
53. Perez-Mutul J., Gonzalez-Herrera L., Sosa-Cabrera T., et al. A mutation in the 5,10-methylenetetrahydrofolate reductase gene is not associated with preeclampsia in women of southeast Mexico. Arch Med Res 2004, 35:231-234.
54. Yilmaz H., Unlucerci Y., Gurdol F., et al. Association of pre-eclampsia with hyperhomocysteinaemia and methylenetetrahydrofolate reductase gene C677T polymorphism in a Turkish population. Aust NZ J Obstet Gynaecol 2004, 44:423-427.
55. Williams M.A., Sanchez S.E., Zhang C., et al. Methylenetetrahydrofolate reductase 677 C-->T polymorphism and plasma folate in relation to pre-eclampsia risk among Peruvian women. J Matern Fetal Neonatal Med 2004, 15:337-344.
56. Pegoraro R.J., Chikosi A., Rom L., et al. Methylenetetrahydrofolate reductase gene polymorphisms in black South Africans and the association with preeclampsia. Acta Obstet Gynecol Scand 2004, 83:449-454.
57. De Maat M.P., Jansen M.W., Hille E.T., et al. Preeclampsia and its interaction with common variants in thrombophilia genes. J Thromb Haemost 2004, 2:1588-1593.
58. Davalos I.P., Moran M.C., Martinez-Abundis E., et al. Methylenetetrahydrofolate reductase C677T polymorphism and Factor V Leiden variant in Mexican women with preeclampsia/eclampsia. Blood Cells Mol Dis 2005, 35:66-69.
59. Also-Rallo E., Lopez-Quesada E., Urreizti R., et al. Polymorphisms of genes involved in homocysteine metabolism in preeclampsia and in uncomplicated pregnancies. Eur J Obstet Gynecol Reprod Biol 2005, 120:45-52.
60. Mello G., Parretti E., Marozio L., et al. Thrombophilia is significantly associated with severe preeclampsia: results of a large-scale, case-controlled study. Hypertension 2005, 46:1270-1274.
61. Driul L., Damante G., D'Elia A., et al. Genetic thrombophilias and uterine artery Doppler velocimetry and preeclampsia. Int J Gynaecol Obstet 2005, 88:265-270.
62. Dalmaz C.A., Santos K.G., Botton M.R., et al. Relationship between polymorphisms in thrombophilic genes and preeclampsia in a Brazilian population. Blood Cells Mol Dis 2006, 37:107-110.
63. Demir S.C., Evruke C., Ozgunen T., et al. The relationship between pregnancy induced hypertension and congenital thrombophilia. Saudi Med J 2006, 27:1161-1166.
64. Zhang Z.H., Zhang R.J., Liu A.M., et al. Study on eNOS gene and MTHFR gene polymorphisms in preeclampsia. J Birth Health Hered 2007, 15:21-23. (in Chinese).
65. Nagy B., Hupuczi P., Papp Z. High frequency of methylenetetrahydrofolate reductase 677TT genotype in Hungarian HELLP syndrome patients determined by quantitative real-time PCR. J Hum Hypertens 2007, 21:154-158.
66. Dusse L.M., Carvalho M.G., Braganca W.F., et al. Inherited thrombophilias and pre-eclampsia in Brazilian women. Eur J Obstet Gynecol Reprod Biol 2007, 134:20-23.
67. Stonek F., Hafner E., Philipp K., et al. Methylenetetrahydrofolate reductase C677T polymorphism and pregnancy complications. Obstet Gynecol 2007, 110(2 Pt 1):363-368.
68. Shen X.N., Huang Y.P., Tang S.H., et al. The relationship between the polymorphism of MTHFR gene and pre-eclampsia. J Pract Obstet Gynecol 2009, 25:236-238. (in Chinese).
69. Wang S.M., Wang L.G., Liu X.J., et al. Investigation on the association between MTHFR gene C677T polymorphism and pre-eclampsia. Maternal and Child Health Care of China 2008, 23:552-554. (in Chinese).
70. Zhang X.Y., Sun D., Sun J. The relationship between plasma homocysteine and preeclampsia. J Perinat Med 2008, 114:245-248. (in Chinese).
71. Canto P., Canto-Cetina T., Juarez-Velazquez R., et al. Methylenetetrahydrofolate reductase C677T and glutathione S-transferase P1 A313G are associated with a reduced risk of preeclampsia in Maya-Mestizo women. Hypertens Res 2008, 31:1015-1019.
72. Stiefel P., Miranda M.L., Bellido L.M., et al. Genotype of the CYBA promoter -930A/G, polymorphism C677T of the MTHFR and APOE genotype in patients with hypertensive disorders of pregnancy: an observational study. Med Clin (Barc) 2009, 133:657-661.
73. Muetze S., Leeners B., Ortlepp J.R., et al. Maternal factor V Leiden mutation is associated with HELLP syndrome in Caucasian women. Acta Obstet Gynecol Scand 2008, 87:635-642.
74. Kahn S.R., Platt R., McNamara H., et al. Inherited thrombophilia and preeclampsia within a multicenter cohort: the Montreal Preeclampsia Study. Am J Obstet Gynecol 2009, 200:151.e1-151.e9. discussion e1-5.
75. Klai S., Fekih-Mrissa N., El H.S., et al. Association of MTHFR A1298C polymorphism (but not of MTHFR C677T) with elevated homocysteine levels and placental vasculopathies. Blood Coagul Fibrinolysis 2011, 22:374-378.
76. Mislanova C., Martsenyuk O., Huppertz B., et al. Placental markers of folate-related metabolism in preeclampsia. Reproduction 2011, 142:467-476.
77. Aggarwal S., Dimri N., Tandon I., et al. Preeclampsia in North Indian women: the contribution of genetic polymorphisms. J Obstet Gynaecol Res 2011, 37:1335-1341.
78. Dissanayake V.H., Sirisena N.D., Weerasekera L.Y., et al. Candidate gene study of genetic thrombophilic polymorphisms in pre-eclampsia and recurrent pregnancy loss in Sinhalese women. J Obstet Gynaecol Res 2012, 38:1168-1176.
79. Said J.M., Higgins J.R., Moses E.K., et al. Inherited thrombophilias and adverse pregnancy outcomes: a case-control study in an Australian population. Acta Obstet Gynecol Scand 2012, 91:250-255.
80. Lykke J.A., Bare L.A., Olsen J., et al. Thrombophilias and adverse pregnancy outcomes: results from the Danish National Birth Cohort. J Thromb Haemost 2012, 10:1320-1325.
81. Arngrimsson R., Bjornsson S., Geirsson R.T., et al. Genetic and familial predisposition to eclampsia and pre-eclampsia in a defined population. Br J Obstet Gynaecol 1990, 97:762-769.
82. Roberts J.M., Cooper D.W. Pathogenesis and genetics of pre-eclampsia. Lancet 2001, 357:53-56.
83. Salonen R.H., Lichtenstein P., Lipworth L., et al. Genetic effects on the liability of developing pre-eclampsia and gestational hypertension. Am J Med Genet 2000, 91:256-260.
84. McDowell I.F., Lang D. Homocysteine and endothelial dysfunction: a link with cardiovascular disease. J Nutr 2000, 130:369S-372S.
85. Weiss N., Heydrick S.J., Postea O., et al. Influence of hyperhomocysteinemia on the cellular redox state-impact on homocysteine-induced endothelial dysfunction. Clin Chem Lab Med 2003, 41:1455-1456.